“A RANDOMIZED, OPEN-LABEL, PARALLEL, PROSPECTIVE STUDY COMPARING THE EFFECTIVENESS AND TOLERABILITY OF DULOXETINE, SERTRALINE, AND ESCITALOPRAM IN TREATING MAJOR DEPRESSIVE DISORDER”, A-JMRHS, vol. 4, no. 01, pp. 203–208, Feb. 2026, doi: 10.65605/a-jmrhs.2026.v04.i01.pp203-208.